| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30007273 | HIV | ENSG00000141526.18 | protein_coding | SLC16A3 | No | No | 9123 | O15427 |
| TVIS30002865 | HIV | ENSG00000141526.18 | protein_coding | SLC16A3 | No | No | 9123 | O15427 |
| TVIS30007274 | HIV | ENSG00000141526.18 | protein_coding | SLC16A3 | No | No | 9123 | O15427 |
| TVIS30088393 | HIV | ENSG00000141526.18 | protein_coding | SLC16A3 | No | No | 9123 | O15427 |
| TVIS30078596 | HIV | ENSG00000141526.18 | protein_coding | SLC16A3 | No | No | 9123 | O15427 |
| TVIS30020385 | HIV | ENSG00000141526.18 | protein_coding | SLC16A3 | No | No | 9123 | O15427 |
| TVIS30046012 | HIV | ENSG00000141526.18 | protein_coding | SLC16A3 | No | No | 9123 | O15427 |
| TVIS30046013 | HIV | ENSG00000141526.18 | protein_coding | SLC16A3 | No | No | 9123 | O15427 |
| TVIS30046014 | HIV | ENSG00000141526.18 | protein_coding | SLC16A3 | No | No | 9123 | O15427 |
| TVIS30046015 | HIV | ENSG00000141526.18 | protein_coding | SLC16A3 | No | No | 9123 | O15427 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SLC16A3 |
|---|---|
| DrugBank ID | DB00119 |
| Drug Name | Pyruvic acid |
| Target ID | BE0000449 |
| UniProt ID | O15427 |
| Regulation Type | |
| PubMed IDs | 16213084 |
| Citations | Shimada A, Nakagawa Y, Morishige H, Yamamoto A, Fujita T: Functional characteristics of H+ -dependent nicotinate transport in primary cultures of astrocytes from rat cerebral cortex. Neurosci Lett. 2006 Jan 16;392(3):207-12. Epub 2005 Oct 5. |
| Groups | Approved; Investigational; Nutraceutical |
| Direct Classification | Alpha-keto acids and derivatives |
| SMILES | CC(=O)C(O)=O |
| Pathways | Citrullinemia Type I; 4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency; Glycogenosis, Type IB; Argininemia; Pyruvate Kinase Deficiency; Pyruvate Carboxylase Deficiency; Amino Sugar Metabolism; The Oncogenic Action of Fumarate; 3-Phosphoglycerate Dehydrogenase Deficiency; Glycolysis; Non-Ketotic Hyperglycinemia; 2-Hydroxyglutric Aciduria (D and L Form); Glucose-Alanine Cycle; G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease; Alanine Metabolism; Hyperglycinemia, Non-Ketotic; Cystinosis, Ocular Nonnephropathic; Dimethylglycine Dehydrogenase Deficiency; Glycogenosis, Type VII. Tarui Disease; Dihydropyrimidine Dehydrogenase Deficiency (DHPD); Lactic Acidemia; Homocarnosinosis; Primary Hyperoxaluria Type I; Ornithine Transcarbamylase Deficiency (OTC Deficiency); The Oncogenic Action of L-2-Hydroxyglutarate in Hydroxygluaricaciduria; Sarcosinemia; Urea Cycle; Phosphoenolpyruvate Carboxykinase Deficiency 1 (PEPCK1); Cysteine Metabolism |
| PharmGKB | PA164778686 |
| ChEMBL | CHEMBL1162144 |
